Dr. Lal PathLabs announced the appointment of a new company secretary, Ernst & Young LLP as internal auditors, and A.G. Agarwal & Associates as cost auditors for the next financial year at the board meeting held on May 11, 2023, and recommended a final dividend of Rs. 6 per equity share.